123 related articles for article (PubMed ID: 12402066)
1. Serum soluble interleukin-2 receptor (IL-2R) and immunohistochemical staining of IL-2R/Tac antigen in colorectal cancer.
Sakata H; Murakami S; Hirayama R
Int J Clin Oncol; 2002 Oct; 7(5):312-7. PubMed ID: 12402066
[TBL] [Abstract][Full Text] [Related]
2. Serum soluble interleukin-2 receptor and immunohistochemical staining of IL-2R/Tac antigen in gastric cancer.
Murakami S; Satomi A; Ishida K; Sakata H; Tsuji Y; Hibino S
Oncol Rep; 1996 Jan; 3(1):69-73. PubMed ID: 21594317
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the effect of serum interleukin-6 (IL-6) and soluble IL-6 receptor levels on survival of patients with colorectal cancer.
Yeh KY; Li YY; Hsieh LL; Lu CH; Chou WC; Liaw CC; Tang RP; Liao SK
Jpn J Clin Oncol; 2010 Jun; 40(6):580-7. PubMed ID: 20194250
[TBL] [Abstract][Full Text] [Related]
4. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A
Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976
[TBL] [Abstract][Full Text] [Related]
5. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
6. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble interleukin-2 receptor in patients with perennial allergic rhinitis before and after immunotherapy.
Ohashi Y; Nakai Y; Sakamoto H; Ohno Y; Sugiura Y; Okamoto H; Tanaka A; Kakinoki Y; Kishimoto K; Hayashi M
Ann Allergy Asthma Immunol; 1996 Sep; 77(3):203-8. PubMed ID: 8814045
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of soluble CD30 and other markers in colorectal cancer patients.
Iwagaki H; Hizuta A; Kohka H; Kobashi K; Nitta Y; Isozaki H; Takakura N; Tanaka N
J Med; 1999; 30(1-2):111-21. PubMed ID: 10515247
[TBL] [Abstract][Full Text] [Related]
9. Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer.
Murakami S; Satomi A; Ishida K; Murai H; Matsuki M; Hashimoto T
Cancer; 1994 Nov; 74(10):2745-8. PubMed ID: 7525035
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
11. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
[TBL] [Abstract][Full Text] [Related]
12. Serum soluble interleukin-2 receptor as a predictor of lymph node metastasis in early gastric cancer.
Murakami S; Sakata H; Tsuji Y; Okubo K; Hamada S; Hirayama R
Dig Surg; 2002; 19(1):9-13; discussion 14. PubMed ID: 11961349
[TBL] [Abstract][Full Text] [Related]
13. Changes in the levels of serum-soluble interleukin-2 receptor after surgical stress.
Murakami S; Sakata H; Tsuji Y; Okubo K; Takahashi T; Kikuchi M; Hirayama R
Surg Today; 2003; 33(8):565-70. PubMed ID: 12884092
[TBL] [Abstract][Full Text] [Related]
14. The relationship between soluble interleukin 2 receptor levels and antidouble stranded DNA antibody levels in patients with systemic lupus erythematosus.
Ward MM; Dooley MA; Christenson VD; Pisetsky DS
J Rheumatol; 1991 Feb; 18(2):235-40. PubMed ID: 2023217
[TBL] [Abstract][Full Text] [Related]
15. Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease.
Tesch H; Günther A; Abts H; Jücker M; Klein S; Krueger GR; Diehl V
Am J Pathol; 1993 Jun; 142(6):1714-20. PubMed ID: 8506943
[TBL] [Abstract][Full Text] [Related]
16. [Elevated soluble interleukin-2 receptor and interleukin-2 receptor positive cells in carcinomatous pleural effusions].
Kojiro N; Moriwaki Y; Ito M; Nishiki M; Shirasaka T; Kokubu T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):100-4. PubMed ID: 2355670
[TBL] [Abstract][Full Text] [Related]
17. Levels of serum-soluble receptor for interleukin-2 in patients with colorectal cancer.
Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N
Surg Today; 1998; 28(10):1115-7. PubMed ID: 9786595
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of tissue expression of interleukin-6 in colorectal carcinoma.
Chung YC; Chaen YL; Hsu CP
Anticancer Res; 2006; 26(5B):3905-11. PubMed ID: 17094421
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of the measurement of serum soluble IL-2 receptor alpha chain levels in clinical monitoring of non-Hodgkin lymphoma].
Setoyama Y; Imai J; Ishikawa T; Sakaida H; Takaori-Kondo A; Kawamata S; Uchiyama T
Rinsho Byori; 1994 Aug; 42(8):834-42. PubMed ID: 7933620
[TBL] [Abstract][Full Text] [Related]
20. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
Shaarawy M; Darwish NA; Abdel-Aziz O
J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
